Get started
Author

Simon Brassel

Observed names: S Brassel, S. Brassel
Observed institution: Office Of Health Economics
ORCID: 0000-0001-7574-9671
Observed ORCID: 0000-0001-7574-9671
OpenAlex ID: A5017155931
Realising the broader value of vaccines in the UK
2021 · Simon Brassel, Margherita Neri, et al. · Vaccine X · 25
PDF
Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines
2022 · Eleanor Bell, Simon Brassel, et al. · Vaccines · 24
PDF
Value assessment of antimicrobials using the STEDI framework – How steady is the outcome?
2023 · Simon Brassel, Amer Al Taie, et al. · Health Policy · 12
Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value?
2023 · Margherita Neri, Simon Brassel, et al. · Vaccines · 11
PDF
A benefit-cost analysis quantifying the broader socioeconomic value of adult respiratory vaccination programs in Japan
2025 · Claud Theakston, Matthew Napier, et al. · Expert Review of Vaccines · 9
A Structured Narrative Literature Review of the Broader Value of Adult Immunisation Programmes
2024 · Hania El Banhawi, Eleanor Bell, et al. · Vaccines · 8
The Value of Vaccines in Maintaining Health System Capacity in England
2022 · Simon Brassel, Margherita Neri, et al. · Value in Health · 8
PDF
Challenges in Value Assessment for One-Time Gene Therapies for Inherited Retinal Diseases: Are We Turning a Blind Eye?
2024 · Jake Hitch, Tom Denee, et al. · Value in Health · 6
A cost-benefit analysis of adult immunization programs across ten countries: Modeling the socioeconomic value of immunization for older populations compared to no vaccination
2025 · Sulayman Chowdhury, Simon Brassel, et al. · Human Vaccines & Immunotherapeutics · 5
PDF
The broader socio-economic value of adult respiratory disease vaccinations in the UK – results from a benefit cost analysis
2025 · Cale Harrison, Simon Brassel, et al. · Expert Review of Vaccines · 5
PDF
The Broader Value of Vaccines: The Return on Investment From a Governmental Perspective
2020 · Simon Brassel, Lotte Steuten · RePEc: Research Papers in Economics · 3
Socioeconomic value of adult respiratory vaccination in the United States: a benefit-cost analysis
2026 · Claud Theakston, Tianyan Hu, et al. · Health Affairs Scholar · 2
Recognizing the Broader Value of Meningococcal Vaccination: A Matter of Evidence, Ability, or Willingness?
2023 · Margherita Neri, Simon Brassel, et al. · Value in Health · 2
PDF
Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit–cost analysis
2026 · Ellie Tunnicliffe, Matthew Napier, et al. · Expert Review of Vaccines · 1
Evaluating the socioeconomic value of adult respiratory immunization in Spain: a benefit–cost analysis
2026 · Matthew Napier, Alejandra López-Ibánez de Aldecoa, et al. · Expert Review of Vaccines · 1
PDF
OP137 A Qualitative Exploration Of The National Institute For Health And Care Excellence’s Impact On International Health Technology Assessment
2023 · Nadine Henderson, Simon Brassel, et al. · International Journal of Technology Assessment in Health Care · 1
PDF
PP10 Preventing The Winter Quadruple Threat: The Value Of Hospital Bed Capacity Freed Up By Vaccination
2023 · Margherita Neri, Simon Brassel, et al. · International Journal of Technology Assessment in Health Care · 1
PDF
HPR185 The International Impact of National Institute for Health and Care Excellence (NICE) Decisions
2022 · S Brassel, E Oliver, et al. · Value in Health · 1
PDF
HTA180 The Value-Generation-Value-Recognition Gap for Novel Gene Therapies in European HTA Systems Using X-Linked Retinitis Pigmentosa as a Case Study
2022 · JM Lee, J Hitch, et al. · Value in Health · 1
Delivering the 2.4 Percent: Unlocking UK Pharma R&D Investment through Evidence-Based Policies
2020 · Simon Brassel, Gordon Cookson · 1
The socioeconomic value of adult respiratory vaccination in Australia: a benefit-cost analysis
2026 · Matthew Napier, Angus Macfarlane, et al. · Figshare
The socioeconomic value of adult respiratory vaccination in Australia: a benefit-cost analysis
2026 · Matthew Napier, Angus Macfarlane, et al. · Expert Review of Vaccines
PDF
Investing in enhanced HIV prevention among young men who have sex with men in Brazil: insights from fiscal health modeling
2026 · George Bray, Natalya Danchenko, et al. · Figshare
Investing in enhanced HIV prevention among young men who have sex with men in Brazil: insights from fiscal health modeling
2026 · George Bray, Natalya Danchenko, et al. · Journal of Medical Economics
PDF
Quantifying the societal benefits of adult immunization against respiratory diseases in France: a benefit cost analysis
2026 · Matthew Napier, Simon Brassel, et al. · Expert Review of Vaccines
Works count: 47
Citation count: 127
H-index: 7
I10-index: 4
Year
Topic
Type